Each medication affects glucose metabolism differently, and the transition period can create unpredictable blood sugar fluctuations
If phase 3 results remain positive, regulatory submissions may begin in 2026, meaning orforglipron could become available in late 2026 or 2027, depending on MHRA and NICE approval timelines
Considering ITB represents a key element in interpreting these studies since patients with precipitated death or with an earlier disease progresses rarely develop irAEs
Improved elasticity means skin bounces back better from facial expressions, reducing the permanent etching of expression lines over time
However, we often find that people feel their best when their levels are "optimal," not just "normal." For example, many people with hypothyroidism feel best when their TSH is in the lower half of the range and their Free T4 and Free T3 are in the upper half